Related Experiment Video
Updated: May 29, 2026
06:30
Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
Published on: August 27, 2021
Peptide-displaying phage technology in glycobiology
1Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. michiko@sanfordburnham.org
Glycobiology
|September 21, 2011
Summary
Phage display technology enables the selection of carbohydrate-mimetic peptides for drug discovery. These peptides serve as valuable tools in glycobiology research and can be used to generate novel antibodies.
Area of Science:
- Glycobiology
- Drug Discovery
- Biotechnology
Background:
- Phage display is an emerging technology for identifying novel ligands.
- Carbohydrate-binding proteins play crucial roles in biological processes.
- Developing specific inhibitors and tools for carbohydrate research is essential.
Purpose of the Study:
- To review the applications of peptide-displaying phage technology in glycobiology.
- To highlight the utility of phage display in generating carbohydrate-mimetic peptides and antibodies.
- To showcase the potential of this technology in translational research.
Main Methods:
- Screening peptide-displaying phage libraries with anti-carbohydrate antibodies.
- Selection of peptides that mimic carbohydrate conformations.
- Utilizing phage display for single-chain antibody technology.
Main Results:
- Identification of short peptides that mimic carbohydrate structures.
- Demonstration of peptides as ligands for carbohydrate-binding proteins.
- Generation of high-affinity recombinant anti-carbohydrate antibodies through phage display.
Conclusions:
- Phage display is a powerful tool for discovering carbohydrate-mimetic peptides.
- These peptides can be used as research tools, immunogens, and therapeutic leads.
- The technology facilitates advancements in glycobiology and translational research.
